glp-1 latest How medications are transforming diabetes and weight loss treatment GLP-1 Agonists: A Comprehensive Overview

The reduced glycemic load of meals caused by GLP-1 is very similar to that seen when replacing a meal with a high glycemic index (GI) with that of a low GI [21] (See Fig

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of drugs approved for treating type 2 diabetes, has been explored in patients with NAFLD [10]

Source: SURMOUNT-1 trial data (Jastreboff et al., NEJM 2022) Tip: If side effects are intolerable at a new dose, your prescriber may extend the current level for an additional 4 weeks rather than escalating

67% were women, and 33% were men

This broad receptor distribution underlies the pleiotropic research profile of GLP-1 from appetite and reward behaviour regulation in the central nervous system, to cardioprotective effects in cardiac tissue, to anti-inflammatory and immunomodulatory activity in immune cell models